Product Name
Human Lipocalin-2 Recombinant Rabbit Monoclonal Antibody [PSH13-67] - BSA and Azide free (Capture)
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within Human Lipocalin-2 aa 21-198 (HA211028).
Positive Control
Recombinant Human Lipocalin-2 protein (HA211028).
Tested
Verified (internally validated)
Published
Reported in literature (not internally validated)
Predicted
Predicted reactive (based on sequence homology)
Not recommended
Not recommended (failed internal validation)
Storage Instructions
Store at 2-8℃. Avoid freeze.
Purification Method
Protein A affinity purified.
Function
Lipocalin-2 (LCN2), also known as oncogene 24p3 or neutrophil gelatinase-associated lipocalin (NGAL), is a protein that in humans is encoded by the LCN2 gene. NGAL is involved in innate immunity by sequestering iron and preventing its use by bacteria, thus limiting their growth. It is expressed in neutrophils and in low levels in the kidney, prostate, and epithelia of the respiratory and alimentary tracts. NGAL is used as a biomarker of kidney injury.
Background References
1. Gupta U et al. Increased LCN2 (lipocalin 2) in the RPE decreases autophagy and activates inflammasome-ferroptosis processes in a mouse model of dry AMD. Autophagy. 2023 Jan
2. Zhao RY et al. Role of lipocalin 2 in stroke. Neurobiol Dis. 2023 Apr
Subcellular Location
Secreted, Cytoplasmic granule lumen, Cytoplasmic vesicle lumen.
Synonyms
24p3 antibody
25 kDa alpha 2 microglobulin related subunit of MMP9 antibody
25 kDa alpha-2-microglobulin-related subunit of MMP-9 antibody
Alpha 2 microglobulin related protein antibody
HGNC:6526 antibody
HNL antibody
Lcn 2 antibody
Lcn2 antibody
Lipocalin-2 antibody
Migration stimulating factor inhibitor antibody
Expand
24p3 antibody
25 kDa alpha 2 microglobulin related subunit of MMP9 antibody
25 kDa alpha-2-microglobulin-related subunit of MMP-9 antibody
Alpha 2 microglobulin related protein antibody
HGNC:6526 antibody
HNL antibody
Lcn 2 antibody
Lcn2 antibody
Lipocalin-2 antibody
Migration stimulating factor inhibitor antibody
MSFI antibody
Neutrophil gelatinase associated lipocalin antibody
Neutrophil gelatinase associated lipocalin precursor antibody
Neutrophil gelatinase-associated lipocalin antibody
NGAL antibody
NGAL_HUMAN antibody
Oncogene 24p3 antibody
Oncogenic lipocalin 24p3 antibody
p25 antibody
Siderocalin antibody
siderocalin LCN2 antibody
SV40 induced 24P3 protein antibody
Uterocalin antibody
Collapse
-
Sandwich ELISA analysis of Human Lipocalin-2 matched pair antibodies
Capture: HA725109, Human Lipocalin-2 Rabbit mAb [PSH13-67]
Detector: HA725110, Human Lipocalin-2 Rabbit mAb [PSH13-68]
Elisa assay was performed by coating wells of a 96-well plate with 100 µl per well of capture antibody (HA725109) diluted in carbonate/bicarbonate buffer, at a concentration of 2ug/ml overnight at 4℃. Wells of the plate were washed, blocked with 150 µl 0.05% tween-20 1% BSA blocking buffer, and incubated with serial diluted Recombinant Human Lipocalin-2 protein (HA211028) starting from 6,000 pg/ml to 0 pg/ml and detect antibody (HA725110, Biotin, 0.2 µg/ml) for 1 hour at 30℃ with shaking. Then the plate was washed and incubated with 100 µl per well of SA-HRP for 0.5 hour at 30℃ with shaking. Detection was performed using an Ultra TMB Substrate for 10 minutes at room temperature in the dark. The reaction was stopped with sulfuric acid and absorbances were read on a spectrophotometer at 450 nm.
-
Interpolated concentrations of native Lipocalin-2 in human samples.
Capture: HA725109, Human Lipocalin-2 Rabbit mAb [PSH13-67]
Detector: HA725110, Human Lipocalin-2 Rabbit mAb [PSH13-68]
Interpolated concentration of native Lipocalin-2 was measured in duplicate at different sample concentrations. The interpolated dilution factor corrected values were plotted (mean +/- SD, n=2). The mean Lipocalin-2 concentration was determined to be 269,116 pg/mL in A431 cell culture supernatant and 2,421pg/mL in Human urine.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"